TrialCancer discovery2022

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.

Phillip M Rappold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.